Aging and Innate Immunity  by Solana, Rafael et al.
Immunity 24, 491–494, May 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.05.003CommentaryAging and Innate ImmunityRafael Solana,1,* Graham Pawelec,2
and Raquel Tarazona3
1Department of Cellular Biology, Physiology,
and Immunology
University of Co´rdoba
E-14004 Co´rdoba
Spain
2Center for Medical Research
University of Tu¨bingen
D-72076 Tu¨bingen
Germany
3Immunology Unit
Department of Physiology
University of Extremadura
E-10071 Ca´ceres
Spain
Adaptive immunity undergoes severe deterioration
with age and represents the main problem in the
elderly. However, evidence accumulated over the last
decade supports the hypothesis that aging also has
a profound impact on innate immunity, which in turn
markedly impacts the health and longevity of older
people.
The aged immune system is less able to mount an
effective immune response after challenges with infec-
tious pathogens than the young because of complex
changes collectively termed ‘‘immunosenescence.’’
This condition has been demonstrated in diverse spe-
cies including humans and contributes to morbidity
and mortality due to the greater incidence or reacti-
vation of infectious diseases, as well as the possible
enhanced susceptibility to autoimmune diseases and
cancer (Pawelec et al., 2002).
Human aging is generally accompanied by elevated
systemic inflammatory conditions. Thus, inflammation-
related biomarkers are powerful predictors of frailty
and mortality in the elderly (DeMartinis et al., 2006),
and this phenomenon is referred to as ‘‘inflamm-aging’’
(Franceschi et al., 2000). In aged subjects, the alter-
ations in the production of inflammatory mediators
might be caused by preexisting conditions such as
autoimmune or degenerative diseases, cancer, or other
factors that diminish the ability to combat infections.
However, they may also result from age-associated
intrinsic defects in the innate immune system, one of
the major functions of which is to maintain the cytokine
balance and control inflammation.
Studies in the immune system in elderly humans and
old mice have clearly demonstrated that adaptive immu-
nity suffers a severe deterioration with age, likely due to
a combination of intrinsic and extrinsic factors (see
Weng, 2006, in this issue of Immunity). Thus, whereas
thymic involution, presumed to be intrinsic, is one of
the main causes of the well-accepted decrease in num-
*Correspondence: rsolana@uco.esbers of naive T cells in the elderly, persistent life-long
antigenic stress from immunosurveillance against per-
sistent viruses, especially cytomegalovirus (CMV), is
responsible for the accumulation of effector-memory
CD8+ T cells and the marked reduction of the T cell rep-
ertoire observed with age (Pawelec et al., 2005; Tara-
zona et al., 2000). In contrast, in the complex scenario
of immunosenescence, it had been generally accepted
that some aspects of innate immunity, e.g., phagocyto-
sis and natural killer (NK) cell cytotoxicity, remain largely
unaffected (Pawelec et al., 1998). However, a more de-
tailed analysis has demonstrated a profound impact of
aging on cells involved in the innate immune response.
Cellular components of the innate immune system,
including neutrophils and macrophages, are the first to
arrive at the site of infection. Their role is to initiate an
inflammatory response, phagocytose the pathogen,
recruit NK cells, and facilitate the maturation and migra-
tion of dendritic cells (DCs) that will regulate and deter-
mine the nature of the T cell-mediated outcome. Thus,
alterations in innate immunity in the elderly have great
importance for pathogen resistance. Here we discuss
the hitherto underappreciated impact of age-associated
changes in the innate immune system.
Phagocytosis and Elimination of Pathogens
Phagocytes play an essential role during the first phase
of the immune response against pathogens and are
major constituents of innate immunity, contributing to
inflammatory responses. Innate immune recognition of
pathogens relies on a set of germline-encoded pattern
recognition receptors (PRRs) that recognize conserved
molecular structures related to microorganisms (also
known as pathogen-associated molecular patterns).
The best characterized of these receptors are the Toll-
like receptors (TLRs) (Akira et al., 2006). Ligation of
TLRs on neutrophils enhances phagocytosis of patho-
gens and release of antimicrobial peptides, and through
the production of chemokines, it recruits and activates
other immune cells at the site of the infection. Although
the elderly preserve the number and phagocytic capac-
ity of neutrophils, other functional characteristics of
these cells are altered during aging (Figure 1). For exam-
ple, receptor-driven functions such as superoxide anion
production, chemotaxis, and apoptosis are reduced. A
decrease in signaling elicited by specific receptors and
alterations in the neutrophil membrane lipid rafts are
involved in the defective function of neutrophils with ad-
vancing age (Fulop et al., 2004). In particular, although
the expression of receptors such as TLRs and GM-CSF
receptor is not diminished, their ligation results in al-
tered signal transduction, possibly as a consequence
of changes to the structure, dynamics, and function of
lipid rafts (Fulop et al., 2004). In young individuals, lipo-
polysaccharide (LPS) stimulation induces the recruit-
ment of TLR4 in both membrane raft and nonraft frac-
tions. In contrast, in the elderly, LPS stimulation does
not induce changes in the recruitment of TLR4 into the
lipid rafts (Fulop et al., 2004). In addition, activation
through GM-CSF receptor is altered in the elderly.
Whereas in young individuals the binding of GM-CSF
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492Figure 1. Effects of Aging on Cellular Components of the Innate Immune Systemto its receptor induces the displacement of Src homol-
ogy (SH) domain-containing protein tyrosine phospha-
tase-1 (SHP-1) from the lipid rafts, in the elderly, this
phosphatase is not downregulated (Fortin et al., 2006).
Because the function of SHP-1 is to dephosphorylate
proteins involved in activation pathways, the presence
of the phosphatase in the lipid raft would block cell
activation, contributing to the decreased response to
GM-CSF observed in neutrophils from elderly individ-
uals.
The phagocytic function of macrophages is also im-
paired with age (Figure 1). Macrophages are a heteroge-
neous group of phagocytes present in most tissues that
are implicated in inflammatory and immunological re-
sponses. Thus, macrophages play an essential role as
sensors of exogenous and endogenous danger signals
through pattern recognition receptors including TLRs.
Although the number of monocytes in peripheral blood
does not change substantially with age, decreased
number of macrophage precursors and bone marrow
macrophages has been observed in humans (Plowden
et al., 2004). Moreover, in elderly individuals, the phago-
cytic ability of macrophages decreases in parallel with
reduced production of macrophage-derived cytokines
(Plowden et al., 2004). However, endocytic receptors in-
volved in the phagocytic process and their signal trans-
duction have not yet been analyzed in relation to aging.
Similar to neutrophils, aging also affects the production
of superoxide anion and nitrous oxide. Altered re-
sponses to chemotactic stimuli and decreased chemo-
kine production have also been described (Plowden
et al., 2004; Gomez et al., 2005). The analysis of TLR ex-
pression in macrophages from aged mice has so far
yielded somewhat discrepant results. In one report, no
changes were found in the expression of TLR2 and
TLR4 on splenic macrophages analyzed by flow cytom-
etry, but another study showed decreased expression of
TLR1 through TLR9. However, both studies agreed that
defects in TLR function were present (Boehmer et al.,
2005; Plowden et al., 2004). Altered signal transductionpathways could be involved in the defective production
of cytokines by aged macrophages after TLR stimula-
tion (Gomez et al., 2005; Boehmer et al., 2005). Together,
these alterations in neutrophil and macrophage func-
tions and signaling pathways associated with aging
may be responsible for the changes observed in phago-
cyte functions and contribute to the substantial increase
in infections in old age.
Antigen Presentation
Macrophages express MHC class II molecules and are
involved in the initiation of the adaptive immune
response against pathogens by acting as antigen-
presenting cells (APCs). Antigen presentation by macro-
phages is decreased with age, possibly due to dimin-
ished expression of MHC class II molecules both in
humans and mice (Plowden et al., 2004; Herrero et al.,
2001). In addition, the induction of the MHC class II
gene (H2-Ab1) in response to IFN-g is impaired in macro-
phages from aged mice due to the decreased binding of
transcription factors to the W and X boxes of the
promoter (Herrero et al., 2001). Moreover, activated
macrophages from aged humans and mice produce
higher amounts of prostaglandin E2 than younger indi-
viduals, which inhibits surface expression of MHC class
II, thus contributing to the decreased capacity of antigen
presentation of macrophages observed with age (Plow-
den et al., 2004).
Dendritic cells (DCs) are the primary APCs, and activa-
tion of DCs through PRRs such as TLRs induces their
maturation and migration to secondary lymphoid organs
where they present antigens to T cells and initiate an
immune response. Most studies on age-associated
changes in the phenotype and function of DCs have an-
alyzed the characteristics of Langerhans cells (LCs) in
the skin (Figure 1). A decrease in the number of these
cells has been described in elderly people and old
mice. However, it is not clear whether this defect is
a consequence of diminished bone marrow precursor
production. LC migration to lymph nodes is also de-
creased in aged mice. This defect may be secondary to
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provides an autocrine stimulus for migration and pro-
vokes the production of TNF-aby adjacent keratinocytes,
which also activates LC mobilization (Cumberbatch
et al., 2002).
In contrast to macrophages, DCs from healthy elderly
people seem to retain their capacity to efficiently pres-
ent antigen to T cells, suggesting that age-related de-
cline of T cell function is not the consequence of altered
antigen presentation (Lung et al., 2000). However, DCs
from frail elderly people may have decreased expression
of costimulatory molecules and IL-12 production and
therefore impaired ability to induce T cell proliferation.
It has been hypothesized that in the healthy elderly,
age-related changes in the T cell compartment can be
compensated by a boost in DC function (Uyemura
et al., 2002). In addition, the production of IL-10 is ele-
vated in elderly individuals and may inhibit DC matura-
tion and macrophage function (Uyemura et al., 2002).
Overall, the exact picture regarding DC dysfunction
with aging is still emerging.
NK Cell Cytotoxicity as a Biomarker of Healthy Aging
NK cells are one of the cellular mediators of innate de-
fense and have been extensively studied in the elderly.
The functional status of NK cells is the result of a balance
between activating and inhibitory signals delivered by
specific membrane receptors. Thus, NK cell killing of
target cells requires not only the interaction of activating
NK receptors with their ligands on the targets but also
the lack of inhibitory signals initiated by the interaction
of NK inhibitory receptors with target MHC class I mole-
cules. Many NK receptors have been described to have
a role in the recognition and regulation of cytotoxicity of
tumor cells and virally infected cells (Bottino et al., 2006).
Cumulative evidence in the last two decades supports
the importance of NK cell activity in maintaining good
health during aging. Well-preserved NK cell cytotoxicity
is observed in healthy elderly individuals and in cen-
tenarians, in particular in those with other criteria of
healthy status such as physical fitness, independence
to perform daily activities, or adequate cognitive func-
tion (Solana and Mariani, 2000). On the contrary, elderly
individuals suffering from chronic diseases and frail el-
derly are characterized by lower NK cytotoxicity. Thus,
low NK activity is associated with development of infec-
tions and death due to infection (Ogata et al., 2001), as
well as with other medical disorders such as atheroscle-
rosis (Bruunsgaard et al., 2001). Furthermore, high NK
cell cytotoxicity is related to better health status and
lower incidence of respiratory tract infections in elderly
individuals, as well as better development of protective
antibody titers in response to influenza vaccination
(Mysliwska et al., 2004). Together, these results support
the hypothesis that high NK cytotoxicity can be consid-
ered a biomarker of healthy aging and longevity,
whereas low NK cytotoxicity is a predictor of morbidity
and mortality due to infections (Figure 1). These studies
could explain previous discrepancies on the effect of
aging on NK cell cytotoxicity that did not consider the
health status of the subjects studied and underscore
the necessity of studies not only in healthy elderly indi-
viduals but also in nonhealthy or frail elderly, who have
a higher risk of infection and related complications and
represent the majority of elderly individuals.The maintenance of NK cell activity in healthy elderly
individuals is associated with an increased number of
NK cells indicating that there is a decrease in cytotoxic-
ity per NK cell in the aged, probably due to inefficient
signal transduction (Solana and Mariani, 2000). Little is
known about any changes in the expression and func-
tion of activating and inhibitory NK receptors in the el-
derly. However, NK cell activation mediated by CD16,
the FcgRIII, seems unaffected by aging, indicating that
NK activation and cytotoxic granule release remain
intact (Solana and Mariani, 2000; Bruunsgaard et al.,
2001; Lutz et al., 2005). Because the per-cell cytotoxicity
against conventional NK targets is decreased in the
elderly, the maintenance of CD16-mediated killing
supports the view that either the expression or the func-
tionality of other NK-activating receptors is defective in
the elderly, or that there is overexpression of inhibitory
receptors. NK cells from elderly individuals present an
age-related increase in killer cell immunoglobulin-like
receptor (KIR) expression and a reciprocal decrease in
CD94-NKG2A expression, although the CD94-NKG2A
inhibitory signaling pathway is intact (Lutz et al., 2005).
The ability of IFN-a and IFN-b to enhance cytotoxicity
of NK cells is also decreased with age, both in mice
and humans. This defect could be related to the delay
in clearance of virus after infection observed in aged
mice, but this hypothesis requires further evaluation
(Murasko and Jiang, 2005). In addition, the secretion of
IFN-g after stimulating purified NK cells with IL-2 also
shows an early decrease, which can be overcome by
prolonging the incubation time (Murasko and Jiang,
2005). NK cells from healthy elderly subjects retain the
ability to synthesize chemokines and express the corre-
sponding chemokine receptors. IL-12 or IL-2 can upre-
gulate chemokine production although to a lesser extent
than that observed in young subjects (Mariani et al.,
2002). Therefore, these results collectively suggest
that NK cells have an age-associated defect in their re-
sponse to cytokines with a subsequent detriment in their
capacity both to kill target cells and to synthesize cyto-
kines and chemokines. Correlations between integrity of
the NK system and health and longevity suggest that
much more research should be focused on the age-
related changes of NK cells with a view to preventing
or reversing their compromised function.
Conclusions and Perspectives
Scientific and technical progress during the last few
years has increased our knowledge of the innate im-
mune response. Thus, the definition of new receptors
on cells of the innate immune system, the advances in
understanding the interactions among these cells to or-
chestrate adequate but not overzealous inflammatory
and immune responses against pathogens, together
with the advances in knowledge of signal transduction
pathways and activation, compel additional efforts to
further analyze how the aging process itself affects
these aspects of innate immunity. The tools available
at present, including proteomics and genomics, will
allow us to identify the molecular mechanisms that con-
tribute to the age-related dysfunction of the innate im-
mune response and to initiate therapies to correct them.
Despite the maintenance of some innate immune
functions in the healthy elderly, an increasing body of
evidence indicates that aging has a negative effect on
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innate immunity is severely diminished in nonhealthy
and frail elderly, and this dysfunction contributes to
the decline of the overall immune responses and to in-
creased morbidity and mortality in the elderly due to
infection. Thus, studies that analyze innate immunity in
elderly individuals that are not affected by clinical condi-
tions that could influence the immune system nor using
drugs that could interfere with immunological parame-
ters are able to provide information mainly on the intrin-
sic effect of aging on innate immunity. In contrast, those
studies performed in nonhealthy or frail elderly are bi-
ased by the cumulative effect of extrinsic factors such
as inflammatory diseases, chronic infections, cancer,
malnutrition, or cognitive disorders. However, it is nec-
essary to foster studies on innate immunity not only in
healthy elderly individuals but also in nonhealthy and
frail elderly, as these subjects are at higher risk of infec-
tion and related complications and represent the major-
ity of elderly individuals. As innate immunity is the first
line of defense against pathogens, boosting innate im-
munity in aged individuals may become an alternative
strategy to fight infection and improve quality of life, pro-
vided that exacerbation of inflammatory conditions can
be avoided.
The possibility to extend the immunological compo-
nent of longitudinal investigations will help to under-
stand the significance of alterations of the innate
immune system as biomarkers of healthy aging and lon-
gevity. Longitudinal studies offer the only possibility in
humans to track which changes in the innate immune
system are really relevant to morbidity and mortality.
Thus far, only certain aspects of adaptive immunity
and parameters of inflammation have been considered
in these exceptionally informative studies (Pawelec
et al., 2005; Wikby et al., 2005), but to obtain a complete
picture, assays of innate immunity must be included in
these and other longitudinal studies in future.
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